Notice of Intent (NOI) to Sole Source proprietary prodrug MP201 to ISB for testing Acute Stress Reactions (ASRs)
Open Special Notice Posted
- Solicitation number
- HT9426-27-NOI-049825
- Agency
- Not on record
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Blue Bell, Pennsylvania, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency Contracting Activity (DHACA) is issuing a Notice of Intent to sole source the proprietary prodrug MP201 to Mitochon Pharmaceuticals, Inc. on behalf of the Walter Reed Army Institute of Research (WRAIR), Center for Military Psychiatry and Neuroscience, Integrative Systems Biology (ISB) Branch, with capability statements due 2:00 p.m. Eastern Time on December 31, 2026. No set-aside is used. The notice seeks two batches of freshly synthesized MP201 for testing Acute Stress Reactions (ASRs), formulated for oral administration in mice at approximately 8-80 mg/kg body weight. The contractor would also provide quality control documentation, dosage background information, and informational support to the ISB team for reports and manuscripts on MP201. The procurement falls under NAICS 541715 and PSC AN14, with a small business size standard of 1,000 employees. Interested parties submit capability statements in PDF, MS Word, or Excel format, with supporting evidence of their ability to provide the stated capability, to Herbert Keen (herbert.e.keen.civ@health.mil) and Lance Nowell (lance.l.nowell.civ@health.mil). The Government reserves the right to determine whether competition is in its best interest, and if no responses are received, DHACA will proceed with the sole source award to Mitochon Pharmaceuticals, Inc. Submitted materials will not be returned, and classified material must not be submitted.
Notice text
See Attachment. Notice of Intent to Sole Source - M201 ProDrug_Approved for posting 16NOV26
Files
| File | Type | Posted |
|---|---|---|
| Notice of Intent to Sole Source - M201 ProDrug_Approved for posting 16NOV26.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source the Co-sponsorship of a Forum on Traumatic Brain Injury with the National Academies of Science, Engineering, and Medicine (NASEM) | — | No set-aside | |
| Software Licenses for Clarivate Cortellis | Department of Health and Human Services | No set-aside | |
| Severe Ocular Surface (SOS) Support and Training Services | Defense Health Agency | No set-aside | |
| SAFE-PLASMA Protocol | — | No set-aside | |
| PANDHA-26-P-0000 044380 Utilities Recompete | — | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity